degarelix accord
accord healthcare s.l.u. - degarelix acetate - neoplasmas prostáticos - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
leuprocad 3.75 mg polvo y disolvente para suspension inyectable de liberacion prolongada
drogueria cadillo s.a.c - droguerÍa - polvo y disolvente para suspension inyectable de liberacion prolongada - por vial 5.00 ml - - leuprorelina
lutrate depot 22.5mg polvo y disolvente para suspension inyectable de liberacion prolongada
global med farma s.a.c. - droguerÍa - polvo y disolvente para suspension inyectable de liberacion prolongada - por jeringa precargada 2.00 ml - - leuprorelina
lupridex depot 7.5mg polvo y disolvente para suspension inyectable de liberacion prolongada
ds pharma peru s.a.c. - droguerÍa - polvo y disolvente para suspension inyectable de liberacion prolongada - por vial - - leuprorelina
firmagon
ferring pharmaceuticals a/s - degarelix - neoplasmas prostáticos - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
lectrum 3.75mg polvo liofilizado para suspension inyectable
novartis biosciences peru s.a. - polvo liofilizado para suspension inyectable - por ampolla - leuprorelina
bisolvomicin
por vial ; acetato de leuprorelina 7.500000 mg; - leuprorelina
lupron depot 11 25 mg polvo para solucion inyectable
abbott laboratorios s.a. - polvo para solucion inyectable - por ; acetato de leuprorelina 11.250000 mg; - leuprorelina
eligard mensual 7,5 mg 1 xeringa prec pols+disolv
eligard trimestral 22,5 mg 1 jer prec pols+disolv